Riccardi, C.; Musumeci, D.; Trifuoggi, M.; Irace, C.; Paduano, L.; Montesarchio, D.
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity. Pharmaceuticals 2019, 12, 146.
https://doi.org/10.3390/ph12040146
AMA Style
Riccardi C, Musumeci D, Trifuoggi M, Irace C, Paduano L, Montesarchio D.
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity. Pharmaceuticals. 2019; 12(4):146.
https://doi.org/10.3390/ph12040146
Chicago/Turabian Style
Riccardi, Claudia, Domenica Musumeci, Marco Trifuoggi, Carlo Irace, Luigi Paduano, and Daniela Montesarchio.
2019. "Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity" Pharmaceuticals 12, no. 4: 146.
https://doi.org/10.3390/ph12040146
APA Style
Riccardi, C., Musumeci, D., Trifuoggi, M., Irace, C., Paduano, L., & Montesarchio, D.
(2019). Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity. Pharmaceuticals, 12(4), 146.
https://doi.org/10.3390/ph12040146